Skip to content
MedsAcross

Brand family

Vyvanse

Lisdexamfetamine · Takeda Pharmaceuticals
United States
Presentations
13
Markets
1

Vyvanse is a brand of Lisdexamfetamine marketed by Takeda Pharmaceuticals, with 13 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Lisdexamfetamine
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
10 mg capsule, 20 mg capsule, 30 mg capsule, 40 mg capsule, 50 mg capsule, 60 mg capsule, 70 mg capsule, 10 mg chewable tablet, 20 mg chewable tablet, 30 mg chewable tablet, 40 mg chewable tablet, 50 mg chewable tablet, 60 mg chewable tablet

All presentations

MedicineManufacturerRegisterAvailability
Vyvanse 10 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 20 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 30 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 40 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 50 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 60 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 70 mg capsuleOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 10 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 20 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 30 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 40 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 50 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Vyvanse 60 mg chewable tabletOralTakeda PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Lisdexamfetamine.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Vyvanse

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.